Search Within

Hong Zhang

Formats
  1. Meeting Abstract (28)
  2. Journal Article (27)
  3. Miscellaneous (1)
  4. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (57)
  2. Sloan Kettering Institute Postdocs (32)
  3. GSK Faculty (31)
  4. GDMT, Pathology and Laboratory Medicine (28)
  5. Gynecology Disease Management Team (28)
  6. Breast Medicine Service (19)

More Groups

People
  1. Edi Brogi (31)
  2. Hannah Wen (31)
  3. Fresia Pareja Zea (29)
  4. Britta Weigelt (28)
  5. Jorge Reis-Filho (28)
  6. Edaise Da Silva (21)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (4)
  4. 2022 (13)
  5. 2021 (8)
  6. 2020 (11)

More Years

Publications
  1. Laboratory Investigation (15)
  2. npj Breast Cancer (7)
  3. Cancer Research (6)
  4. Annals of Oncology (4)
  5. Modern Pathology (4)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. Nature Publishing Group (23)
  2. American Association for Cancer Research (7)
  3. Nature Research (4)
  4. Oxford University Press (4)
  5. BMJ Publishing Group Ltd. (2)
  6. College of American Pathologists (2)

More Publishers

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FOXK2 amplification promotes breast cancer development and chemoresistance
    Journal Article

    Yu, Y.; Cao, W. M.; Cheng, F.; Shi, Z.; Han, L.; Yi, J.; da Silva, E. M.; Dopeso, H.; Chen, H.; Yang, J.; more...
    Cancer Letters (2024)

    Fulltext@MSK | Save
  • Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations
    Journal Article

    Dopeso, H.; Gazzo, A. M.; Derakhshan, F.; Brown, D. N.; Selenica, P.; Jalali, S.; Da Cruz Paula, A.; Marra, A.; da Silva, E. M.; Basili, T.; more...
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Nonlobular invasive breast carcinomas with biallelic pathogenic CDH1 somatic alterations: A histologic, immunophenotypic, and genomic characterization
    Journal Article

    Derakhshan, F.; Da Cruz Paula, A.; Selenica, P.; da Silva, E. M.; Grabenstetter, A.; Jalali, S.; Gazzo, A. M.; Dopeso, H.; Marra, A.; Brown, D. N.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • KIT genetic alterations in breast cancer
    Journal Article

    Vahdatinia, M.; Derakhshan, F.; Da Cruz Paula, A.; Dopeso, H.; Marra, A.; Gazzo, A. M.; Brown, D.; Selenica, P.; Ross, D. S.; Razavi, P.; more...
    Journal of Clinical Pathology (2024)

    Fulltext@MSK | Save
  • Atezolizumab (atezo) and tumour microenvironment in early triple-negative breast cancer (eTNBC): Exploratory biomarker analysis from IMpassion031
    Meeting Abstract

    Harbeck, N.; Duan, C.; DuPree, K.; Chang, C. W.; Barrios, C. H.; Zhang, H. A.; Saji, S.; Jung, K. H.; Telli, M. L.; Liste Hermoso, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Whole-genome sequencing analysis of invasive lobular carcinomas lacking CDH1 alterations
    Meeting Abstract

    Dopeso, H.; Selenica, P.; Derakhshan, F.; Da Cruz Paula, A.; Marra, A.; da Silva, E. M.; Basili, T.; Gazzo, A.; Bhaloo, S.; Oesterreich, S.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • The histologic and genomic features of breast cancers harboring genetic alterations in RecQ DNA helicases
    Meeting Abstract

    Kaur, G.; Selenica, P.; Gazzo, A.; Cartagena, L. C.; Daaboul, F.; Dopeso, H.; da Silva, E. M.; Ross, D.; Zhang, H.; Wen, H.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Breast cancers harboring FANCA genetic alterations
    Meeting Abstract

    Cartagena, L. C.; Marra, A.; Brown, D.; Gazzo, A.; Selenica, P.; Dopeso, H.; da Silva, E. M.; Kaur, G.; Ross, D.; Zhang, H.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer
    Journal Article

    Barrios, C. H.; Saji, S.; Harbeck, N.; Zhang, H.; Jung, K. H.; Patel, S.; Patel, S.; Duc, A. N.; Liste-Hermoso, M.; Chui, S. Y.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save